AAA
AGN

Alpine Associates Advisors’s Allergan plc AGN Stock Holding History

Alpine Associates Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-97,500
Closed -$21.7M – 97
2014
Q2 		$21.7M Buy
+97,500
New +$20.2M 1.01% 29

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Alpine Associates Advisors's AGN Position: Q2 2014 in Review

Alpine Associates Advisors sold out of Allergan plc (AGN) in Q2 2014, closing a stake of 35,800 shares — an estimated $7.41M sold.

Alpine Associates Advisors first reported a position in AGN in Q4 2013 and held it in 2 quarters. The position peaked at $36.7M in Q4 2013. 674 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • Alpine Associates Advisors reported no remaining Allergan plc position as of Q2 2014 after selling out during the quarter.
  • Alpine Associates Advisors sold 35,800 Allergan plc shares in Q2 2014, an estimated $7.41M.
  • Alpine Associates Advisors first reported a position in Allergan plc in Q4 2013 and held it in 2 quarters.
  • Alpine Associates Advisors's Allergan plc position peaked at $36.7M in Q4 2013.
  • 674 funds tracked by Wall St. Rank held Allergan plc as of Q2 2014.

Based on Alpine Associates Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.